MYCN and neuroblastoma: In an attempt to represent the biological diversity of high-risk neuroblastoma, we selected two cell lines: the MYCN-amplified, highly PPM1D-expressing cell line IMR-32, and the 11q-deleted, TP53-mutated cell line SK-N-AS.